ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #2,721Hybrid

Clinical and Experimental Immunology

Acronym:cei
•
Abbreviation (ISO):CLIN EXP IMMUNOL
•
Identifier (ISSN):0009-9104(Print)/1365-2249(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
3.9↑ +0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical and Experimental Immunology

WoS Q2
24683.5420183.7120193.5320204.3320215.7320224.620233.420243.820253.92026
Annual Impact Factor Metric
Current (2026):3.9
Scopus SJR & RankScopus Q1
1.41
#2,721

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
167

167 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate2.9%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
114articles/year
39.08% Gold OA•67.79% Original Research

Aims & Scope

Clinical & Experimental Immunology (established in 1966) is an authoritative international journal publishing high-quality research studies in translational and clinical immunology that have the potential to transform our understanding of the immunopathology of human disease and/or change clinical practice. The journal is focused on translational and clinical immunology and is among the foremost journals in this field, attracting high-quality papers from across the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through scientific studies to the treatment, prevention or diagnosis of human disease. Clinical immunology has evolved as a field to encompass the application of state-of-the-art technologies such as next-generation sequencing, metagenomics and high-dimensional phenotyping to understand mechanisms that govern the outcomes of clinical trials.

Topics Covered (Recognized by AI)
Biology99.9%Medicine99.7%Immunology99%Genetics94%Internal medicine81.4%Chemistry74.5%Biochemistry72.6%Immune system62.3%Antibody54.1%Antigen50.4%Pathology48.6%In vitro39.8%Endocrinology36.1%Gene23.2%Molecular biology22.2%Disease20.1%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q2
Rank78/183
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q2
Rank90/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.9
Articles / Year58
Total Citations26
2025
IF3.8
Articles / Year92
Total Citations233
2024
IF3.4
Articles / Year123
Total Citations882
2023
IF4.6
Articles / Year138
Total Citations1,496
2022
IF5.732
Articles / Year127
Total Citations2,415

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,721Scopus Q1SCImago Profile
Scopus Coverage:1966-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q1
1.41

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
4.17

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,487 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,609
3-Year Documents368
Citable Documents357

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate50.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ1
Immunology and AllergyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.9%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical and Experimental Immunology (acronym: cei, abbr: CLIN EXP IMMUNOL, ISSN: 0009-9104) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in England since 1966. The periodical holds a Journal Impact Factor (JIF) of 3.90, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.410 (Q1), an H-index of 167.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 114 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,487 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1966
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8073409e-e04e-4bdb-950d-8b2c95761f3d
Database Updated: 2026-10-01